CAD 0.04
(16.67%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -813.14 Thousand CAD | -2.26% |
2022 | -795.15 Thousand CAD | 67.0% |
2021 | -2.4 Million CAD | -100.73% |
2020 | -1.2 Million CAD | -37.99% |
2019 | -870.01 Thousand CAD | -71.13% |
2018 | -508.4 Thousand CAD | -726.12% |
2017 | -61.54 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -75.81 Thousand CAD | 56.93% |
2024 Q1 | -176.02 Thousand CAD | 8.31% |
2023 Q4 | -191.97 Thousand CAD | 0.62% |
2023 Q2 | -262.04 Thousand CAD | -60.43% |
2023 FY | -813.14 Thousand CAD | -2.26% |
2023 Q1 | -163.34 Thousand CAD | 2.32% |
2023 Q3 | -193.17 Thousand CAD | 26.28% |
2022 Q2 | -212.29 Thousand CAD | 1.61% |
2022 Q4 | -167.22 Thousand CAD | 16.58% |
2022 FY | -795.15 Thousand CAD | 67.0% |
2022 Q1 | -215.76 Thousand CAD | 88.18% |
2022 Q3 | -200.46 Thousand CAD | 5.57% |
2021 FY | -2.4 Million CAD | -100.73% |
2021 Q2 | -204.7 Thousand CAD | -26.86% |
2021 Q4 | -1.82 Million CAD | -800.81% |
2021 Q3 | -202.6 Thousand CAD | 1.03% |
2021 Q1 | -161.36 Thousand CAD | 30.52% |
2020 Q4 | -232.26 Thousand CAD | 8.5% |
2020 Q3 | -253.82 Thousand CAD | 59.58% |
2020 Q2 | -627.95 Thousand CAD | -466.59% |
2020 FY | -1.2 Million CAD | -37.99% |
2020 Q1 | -110.83 Thousand CAD | 63.37% |
2019 Q2 | -203.96 Thousand CAD | -8.35% |
2019 Q1 | -188.24 Thousand CAD | 8.49% |
2019 FY | -870.01 Thousand CAD | -71.13% |
2019 Q4 | -302.57 Thousand CAD | -114.35% |
2019 Q3 | -141.16 Thousand CAD | 30.79% |
2018 Q2 | -140.74 Thousand CAD | -71.92% |
2018 Q3 | -80.07 Thousand CAD | 43.11% |
2018 FY | -508.4 Thousand CAD | -726.12% |
2018 Q4 | -205.71 Thousand CAD | -156.9% |
2018 Q1 | -81.87 Thousand CAD | -33.86% |
2017 Q4 | -61.15 Thousand CAD | -15910.21% |
2017 FY | -61.54 Thousand CAD | 0.0% |
2017 Q3 | -382.00 CAD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aion Therapeutic Inc. | -6.28 Million CAD | 87.067% |
Ayurcann Holdings Corp. | -3.96 Million CAD | 79.506% |
Blueberries Medical Corp. | -1.63 Million CAD | 50.277% |
The BC Bud Corporation | -1.22 Million CAD | 33.569% |
BioNxt Solutions Inc. | -7.72 Million CAD | 89.471% |
CordovaCann Corp. | -6.88 Million CAD | 88.189% |
Christina Lake Cannabis Corp. | -4.13 Million CAD | 80.32% |
Captor Capital Corp. | -11.38 Million CAD | 92.855% |
City View Green Holdings Inc. | -2.44 Million CAD | 66.791% |
1CM Inc. | -913.85 Thousand CAD | 11.02% |
Global Hemp Group Inc. | -2.58 Million CAD | 68.489% |
Greenway Greenhouse Cannabis Corporation | -4.72 Million CAD | 82.782% |
IM Cannabis Corp. | -9.49 Million CAD | 91.439% |
Lobe Sciences Ltd. | -4.7 Million CAD | 82.726% |
Maple Leaf Green World Inc. | -1.09 Million CAD | 25.504% |
Mountain Valley MD Holdings Inc. | -7.67 Million CAD | 89.398% |
Nextleaf Solutions Ltd. | 223.33 Thousand CAD | 464.095% |
Pharmadrug Inc. | -13.2 Million CAD | 93.84% |
Captiva Verde Wellness Corp. | -6.08 Million CAD | 86.637% |
RAMM Pharma Corp. | -7.72 Million CAD | 89.468% |
RIV Capital Inc. | -106.76 Million CAD | 99.238% |
Revive Therapeutics Ltd. | -5.61 Million CAD | 85.528% |
Red White & Bloom Brands Inc. | -138.89 Million CAD | 99.415% |
SLANG Worldwide Inc. | -19.36 Million CAD | 95.801% |
1933 Industries Inc. | -13.36 Million CAD | 93.915% |
Red Light Holland Corp. | -7.62 Million CAD | 89.339% |
Top Strike Resources Corp. | -1.72 Million CAD | 52.725% |
Xebra Brands Ltd. | -1.95 Million CAD | 58.457% |
Adastra Holdings Ltd. | -3.54 Million CAD | 77.06% |